John K Forrest
MD, FACC, FSCAI
Associate Professor of Medicine (Cardiovascular Medicine); Director of Interventional Cardiology, Cardiovascular Medicine; Director of Structural Heart Disease, Yale Medicine; Director, Structural Heart Disease Program, Cardiovascular Medicine
Biography
Research & Publications
Patient Care
News
Locations
Appointments
Education & Training
- FellowshipYale University School of Medicine (2012)
- FellowshipYale University (2010)
- ResidencyYale-New Haven Hospital/Traditional Program (2008)
- InternshipYale-New Haven Hospital/Traditional Program (2006)
- MDYale University School of Medicine (2005)
Activities
- TAVR in Women and BicuspidsVirtual Meeting 2021
- Update on Evolut Low Risk TrialVirtual Conference 2021
- Management of Coronary Disease Pre-and Post TAVR: Guidelines, Tips and TricksOn-line Virtual Conference 2020
- Primary Results of Evolut Low Risk Bicuspid StudyVirtual Conference 2020
- Critical Review of Evidence: TAVR in Low Risk Bicuspid PatientsVirtual Conference 2020Society for Cardiovascular Angiography and Interventions Annual Meeting 2020
- Blueprint for Bicuspid Treatment: TAVR Implant Strategies for Bicuspid PatientsVirtual Conference 2020
- TAVR Optimization Strategies in Complex Anatomies: BicuspidVirtual Conference 2020Transcatheter Cardiovascular Therapeutics Annual Meeting 2020
- Evolut Platform: Design Features, Outcomes, Implantation Tips and Tricks and Future VisionsVirtual Conference 2020
- Most Frequently Used TAVR Systems: An Update on EvolutVirtual Conference 2020
- TAVR in Bicuspid Aortic ValvesSan Francisco, United States 2019
- TAVR with High Risk for Coronary ObstructionSan Francisco, United States 2019
- TAVR Foundations for FellowsSan Francisco, United States 2019
- Latest Clinical Data in Bicuspid DiseaseChicago, United States 2019
- Valvular Heart Disease in 2019: A Field TransformedNew Orleans, United States 2019
- Transcatheter Therapies: Potential RealizedNew Orleans, United States 2019
- New Technologies for Brain Protection During TAVRLas Vegas, United States 2019
- Con: Cerebral Embolic Protection is a Niche ConceptLas Vegas, United States 2019
- TAVR in Patients with a Bicuspid AnatomyNew York, United States 2019
- Self-Expanding Transcatheter Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Bicuspid Morphology: A Report from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy RegistryWashington, United States 2019
- Paravalvular Leak Post-TAVRSan Diego, United States 2018
- Cerebral Embolic Protection During TAVRSan Diego, United States 2018
- Coronary Obstruction After TAVRSan Diego, United States 2018
- The Road to Perdition: Severe Aortic Stenosis with Bicuspid Valve DiseaseSan Diego, United States 2018
- TAVR Foundations for FellowsSan Diego, United States 2018
- Structural Heart Disease in 2018: Moving from TAVR to TMVR and MoreFarmington, United States 2018
- The Evolut PRO TAVR System: Confronting the Issues (Valve Sizing, New Pacemakers, Paravalvular Leak, and Extreme CalcificationChicago, United States 2018
- Debate: Cerebral Embolic Protection Should be Used in All (Most) CasesChicago, United States 2018
- Challenging Structural Cases by the Experts: Predicting and Managing Coronary Obstruction during TAVRSan Diego, United States 2018
- TAVR Update: Evolut Pro Clinical TrialsMiami, United States 2018
- 30-Day Outcomes Following Transcatheter Aortic Valve Replacement with the Evolut PRO Valve in Commercial Use: Report from the STS/ACC TVT RegistrySan Diego, United States 2018
- TAVR Shift to Intermediate-Risk Patients: Practical Considerations for the Heart Team and HospitalsDenver, United States 2017
- Evolut R TAVR - Technology Review Including Evolut 34mm and PRODenver, United States 2017
- Ask the Experts - How Do I Manage These Challenge Case Scenarios?Chicago, United States 2017
- Optimizing Post-Dilation with Self-Expanding Valves - Does Balloon Choice Matter?Chicago, United States 2017
- Evolut R Snapshots I - The New Evolut R PRO SystemChicago, United States 2017
- Procedural Perfection: Ideal TAVR Using the Evolut - All the Tips and TricksNew Orleans, United States 2017
- How to Build a Successful Multidisciplinary Interventional Program: Balancing Pressures of Good Practice and Good ResearchNew Orleans, United States 2017
- Will SURTAVI Change my Pratice: TAVI for Patients with Intermediate Risk?Paris, France 2017
- Managing Complex Paravalvular LeaksAtlanta, United States 2017
- Next Generation TAVI TechnologiesPrague, Czech Republic 2017
- How to Mitigate the Risk of PVL post TAVRPrague, Czech Republic 2017
- Low Incidence of Paravalvular Leak at 6 Months with the New Self-Expanding Repositionable Transcatheter Aortic Valve with Pericardial WrapDenver, United States 2017
- Transcatheter Mitral Valve-in-Ring with Concomitant Para-Ring Leak ClosureParis, France 2017
- Recorded Case: Transcatheter Aortic Valve Replacement using Evolut Pro ValveParis, France 2017
- 30-Day Safety and Echocardiographic Outcomes Following Transcatheter Aortic Valve Replacement with the Self-Expanding Repositionable Evolut PRO SystemWashington, United States 2017
- All-Cause Mortality or Major Stroke by Valve Size After Self-Expanding Transcatheter Aortic Valve ReplacementSan Francisco, United States 2016
- Complex Cases Using a Self-Expanding TAVRAtlanta, United States 2015
- Current Status of TAVR with the Self-Expanding CoreValve SystemAtlanta, United States 2015
- Debate: Is TAVR or SAVR More Appropriate for All Comers: ProAtlanta, United States 2015
- Transcatheter Aortic Valve Replacement in Women Versus Men: An Analysis of the CoreValve US Pivotal and Continued Access TrialsSan Francisco, United States 2015
- US Perspective: Optimizing Patient Selection and Imaging for TAVRWashington, United States 2014
- Transcatheter Aortic Valve Replacement 2014New London, United States 2014
- Innovation: New Frontier in Implantable Therapies: Clinical Need, Regulatory Challenges, and Market OpportunitiesLondon, United Kingdom 2014
- Treating Iliac, SFA, and Critical Limb Ischemia - Patient Screening, Prognosis, Treatment Options and OutcomesMedellín, Colombia 2014
- A True Hybrid Case: Off-Pump CABG and TAVR (Direct Aortic Approach using a 31mm CoreValve) in Patient with Left Main Disease, Bicuspid Aortic Valve Stenosis, and Severe ThrombocytopeniaWashington, United States 2014
- Focus of TAVR: Program, Patient Selections, and ComplicationsMedellín, Colombia 2013
- Recorded Case: Retrograde RCA CTO via RV Marginal: The Beating CorsairMiami, United States 2012
- Complex Carotid StentingOrlando, United States 2011
- Device Choices for Percutaneous Aortic Paravalvular Leak ClosureVancouver, Canada 2011
- Evaluation of everolimus-eluting and paclitaxel eluting stents in patients with jailed side branches: two-year results from the SPIRIT IV trialParis, France 2011
Honors & Recognition
| Award | Awarding Organization | Date |
|---|---|---|
| ACC Emerging Leadership Faculty | American College of Cardiology | 2019 |
| Yale Advanced Emerging Leadership Program | 2017 | |
| Fellow of the American College of Cardiology | 2016 | |
| Yale-New Haven Hospital Nurses Choice Award | 2016 | |
| Fellow of the Society for Cardiovascular Angiography and Interventions | 2015 |
Professional Service
| Organization | Role | Date |
|---|---|---|
| Yale University- Davenport College | Faculty Fellow at Davenport College Yale University | 2021 - Present |
| Journal of the American Medical Association (JAMA) | Reviewer | 2021 - Present |
| Journal of American College of Cardiology (JACC) | Guest Editor | 2021 - Present |
| Journal of American College of Cardiology (JACC) | Reviewer | 2020 - Present |
| Society for Cardiovascular Angiography and Interventions | Annual Meeting | 2019 - Present |
| Transcatheter Cardiovascular Therapeutics | Abstract Selection Committee | 2019 - Present |
| New England Structural Heart Annual Meeting | Co-Director | 2018 - Present |
| New England Structural Heart Consortium | Board of Directors | 2018 - Present |
| Yale University School of Medicine | Mission Statement Committee | 2018 - 2019 |
| JACC Intervention | Reviewer | 2018 - Present |
| Transcatheter Valve Therapies | Annual meeting (late breaking clinical trials, cases, innovation, moderated posters) reviewer | 2018 - Present |
| American College of Cardiology | Annual session Abstract Selection Committee Aorta Valve Disease | 2018 - Present |
| American College of Cardiology | STS/ACC TVT Risk Model | 2018 - Present |
| Yale University School of Medicine | Quality Committee | 2017 - 2019 |
| Yale-New Haven Hospital | Yale-New Haven Health System Quality Committee | 2017 - 2019 |
| Yale University School of Medicine | Shock Team | 2017 - Present |
| Aorta Journal | Editor | 2017 - Present |
| Transcatheter Cardiovascular Therapies | Annual meeting Session Chair | 2017 - Present |
| Transcatheter Valve Therapies | Annual meeting, Abstract Selection Committee | 2017 - Present |
| Transcatheter Valve Therapies | Annual meeting Session Chair | 2017 - Present |
| American College of Cardiology | TVT Dataset Update | 2017 - Present |
| Yale University School of Medicine | Heart Care Team | 2016 - Present |
| Yale University School of Medicine | Yale Medical Leadership Council | 2015 - Present |
| Yale-New Haven Hospital | Yale-New Haven Patient Experience Committee | 2015 - Present |
| American Journal of Cardiology, Catheterization and Cardiovascular Interventions | Reviewer | 2015 - Present |
| Medtronic | Medtronic Fundamentals of TAVR Fellows Course Co-Director | 2015 - Present |
| Edwards | Edwards TAVR Fellows Course Co-Director | 2015 - Present |
| Medtronic | Medtronic Advanced Users Evolut R Program Co-Chair | 2015 - Present |
| St. Thomas Day School | Member Board of Governor's Vice-Chair Board 2019-2021 Chairman Board 2021-present | 2015 - Present |